GLP-1 functions as an incretin, enhancing glucose-dependent insulin secretion, suppressing glucagon release and delaying gastric emptying
Also, promotes anti-inflammation in the heart, improves insulin sensitivity, is neuroprotective, and reduces alcohol consumption GIP receptor activation enhances insulin secretion, stimulates glucagon to prevent low blood sugar, promotes bone mineral density, is neuroprotective, and lowers blood pressure GCG receptor activation promotes fat metabolism, reduces liver fat, is anti-inflammatory, and increases basal metabolic rate Dosing Subcutaneous 2 mg 16 mg Once a week Morning preferred Healing & Recovery BPC-157 Body Protection Compound (BPC)-157
IV delivery places the administered dose into systemic circulation, but that does not mean 100% enters target cells, remains intact, reaches a specific organ, or produces a clinical benefit
Statistical power is solid for weight loss